Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 58 min ago
Peer-reviewedCC BYBiomedicines

Gilteritinib Suppresses Hepatocellular Carcinoma Cells in Association with Reduced Calpain-1 Expression and Inhibition of STAT3/AKT Signaling

  • Sijing Chen1
  • Yunyang Zhao1
  • Yunqi Pan2
  • Zhihui Zhao1
  • Zhonghua Ma3
  • Yujie Wei2
  • Ting Liu1
  • Limei Shuai1
  • Wenjiao Gu2
  • Shuangyi Li2
  • Junjie Shao2
  • Ying Jiang2
4 more authors
  • Ailifeire Maimaitituerxun2
  • Xinghuai Wang2
  • Xiaochun Zhou4
  • Futian Tang5
5 affiliations
  1. 1School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, China
  2. 2Department of Cardiovascular Disease, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou 730000, China
  3. 3Department of Urology, Minqin County People’s Hospital, Minqin 733300, China
  4. 4Department of Nephrology, Lanzhou University Second Hospital, Lanzhou 730030, China
  5. 5Gansu Province Key Laboratory of Environment Oncology, Lanzhou University Second Hospital, Lanzhou 730030, China
Read full textPDFCite

Related

  1. Inhibition of Bone Morphogenetic Protein 2 Suppresses the Stemness Maintenance of Cancer Stem Cells in Hepatocellular Carcinoma via the MAPK/ERK Pathway [Retraction].
    Cancer management and researchPeer-reviewedCC BY-NCFull textOncologyEurope PMC
  2. Medicarpin suppresses gastric cancer growth in association with inhibition of mevalonate pathway-associated cholesterol biosynthesis
    Kaimeng Huang, Shan Huang, Xing Wang +11
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyFrontiersCrossref
  3. MYC Suppresses Mitochondrial Function in Hepatocellular Carcinoma through NRF1-Driven Receptor-Mediated Mitophagy
    N. P. Lesner, L. C. Kim, S. D. Shelton +7
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  4. Apigenin suppresses ovarian cancer cell growth by disrupting TGF-beta1-mediated cancer–stroma interaction via AKT inhibition
    Youngjoo Kwon, Somin Lee, Hyunjin Seo +1
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Pharmacology & toxicologyCrossref
  5. Culture Dimensionality Shapes Drug Sensitivity to Kinase Inhibitor Combinations with Epigenetic or Metabolic Inhibition in a Hepatocellular Carcinoma Model
    Claudia Kunst, Tobias Schilling, Cedric Arling +4
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC

Cite

BibTeXRIS
BibTeX
@article{chen2026gilteritinib,
  title = {{Gilteritinib Suppresses Hepatocellular Carcinoma Cells in Association with Reduced Calpain-1 Expression and Inhibition of STAT3/AKT Signaling}},
  author = {Sijing Chen and Yunyang Zhao and Yunqi Pan and Zhihui Zhao and Zhonghua Ma and Yujie Wei and Ting Liu and Limei Shuai and Wenjiao Gu and Shuangyi Li and Junjie Shao and Ying Jiang and Ailifeire Maimaitituerxun and Xinghuai Wang and Xiaochun Zhou and Futian Tang},
  journal = {Biomedicines},
  year = {2026},
  month = sep,
  url = {https://europepmc.org/article/PMC/PMC13701972},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Gilteritinib Suppresses Hepatocellular Carcinoma Cells in Association with Reduced Calpain-1 Expression and Inhibition of STAT3/AKT Signaling
AU  - Sijing Chen
AU  - Yunyang Zhao
AU  - Yunqi Pan
AU  - Zhihui Zhao
AU  - Zhonghua Ma
AU  - Yujie Wei
AU  - Ting Liu
AU  - Limei Shuai
AU  - Wenjiao Gu
AU  - Shuangyi Li
AU  - Junjie Shao
AU  - Ying Jiang
AU  - Ailifeire Maimaitituerxun
AU  - Xinghuai Wang
AU  - Xiaochun Zhou
AU  - Futian Tang
PY  - 2026
DA  - 2026/09/22
JO  - Biomedicines
UR  - https://europepmc.org/article/PMC/PMC13701972
SN  - 2227-9059
ER  -